title: Retrospectively comparative evaluation of the first- and second-line chemotherapy with campto and oxaliplatin combined with oral tegafur/uracil (UFT)/leucovorin (LV) in patients with metastatic colorectal cancer.
authors.affiliation: Department of Hema-Oncology, St. Martin De Porres Hospital, Chiayi, Taiwan. hemonc@stm.org.tw
authors.forename: Shih-Chuan
authors.initials: SC
authors.lastname: Hsiao
authors.forename: Jui-Fen
authors.initials: JF
authors.lastname: Lin
authors.forename: Mao-Te
authors.initials: MT
authors.lastname: Chuang
authors.forename: Yu-An
authors.initials: YA
authors.lastname: Lee
authors.forename: Dong-Long
authors.initials: DL
authors.lastname: Wu
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002166:Camptothecin / Q000008:administration & dosage; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D009944:Organoplatinum Compounds / Q000008:administration & dosage; D000077150:Oxaliplatin; D012189:Retrospective Studies; D015996:Survival Rate; D005641:Tegafur / Q000008:administration & dosage; D016896:Treatment Outcome; D014498:Uracil / Q000008:administration & dosage
chemical_list: D009944:Organoplatinum Compounds; D000077150:Oxaliplatin; D005641:Tegafur; D014498:Uracil; D002955:Leucovorin; D002166:Camptothecin